Status:
COMPLETED
Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia
Lead Sponsor:
Escoles Universitaries Gimbernat
Collaborating Sponsors:
Corporacion Parc Tauli
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction: Gastroesophageal reflux disease (GERD) is highly prevalent in our society. The association between GERD and hiatal hernia has been shown to be etiologically critical in the onset or wors...
Eligibility Criteria
Inclusion
- Patients diagnosed with Gastroesophageal Reflux disease (Vakil et al, 2006)
- Age between 18 and 90 years.
- Patients with GERD due to hiatal hernia type I, without surgical indication.
- Patients with GERD due to hiatal hernia type I, with surgical indication on the waiting list.
- Patients with GERD due to hiatal hernia type I, with surgical contraindication.
Exclusion
- That fail to meet inclusion criteria.
- Patients treated with Benzodiazepines (BZD)
- Patients with previous surgical interventions at the abdominal level, especially of supramesocolic structures
- Patients diagnosed with Barrett's esophagus
- Patients with paraesophageal and mixed hiatus hernias
- Diagnosed erosive esophagitis
- Active neoplasm
- Serious psychiatric disorders
- Neuromuscular or neurological injuries
- Aneurysms
- Pregnancy
- Hemophilia or treatment with anticoagulant therapy
- Hypersensitivity of the skin or dermatological diseases in the trunk that prevent the performance of the techniques
- Rejection of manual contact
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05283447
Start Date
May 15 2022
End Date
June 30 2023
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ricard Tutusaus Homs
Sant Cugat del Vallès, Barcelona, Spain, 08174